AR107561A2 - Ensayo elisa para la detección de vegf - Google Patents
Ensayo elisa para la detección de vegfInfo
- Publication number
- AR107561A2 AR107561A2 ARP170100313A ARP170100313A AR107561A2 AR 107561 A2 AR107561 A2 AR 107561A2 AR P170100313 A ARP170100313 A AR P170100313A AR P170100313 A ARP170100313 A AR P170100313A AR 107561 A2 AR107561 A2 AR 107561A2
- Authority
- AR
- Argentina
- Prior art keywords
- vegf
- elisa test
- index
- vegf detection
- pathologies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
La actividad del factor de crecimiento endotelial vascular (VEGF) en el torrente sanguíneo de un paciente o en otra muestra biológica puede servir como índice de diagnóstico y pronostico para el cáncer, diabetes, afecciones cardíacas y otras patologías. Los métodos de ensayo ELISA de tipo sándwich que utilizan anticuerpos y los kits de detección de VEGF como antígeno se proporcionan para detectar los tipos de niveles de VEGF en muestras biológicas de modelos animales y pacientes humanos y pueden ser utilizados como índice de diagnóstico y pronóstico.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82820306P | 2006-10-04 | 2006-10-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR107561A2 true AR107561A2 (es) | 2018-05-09 |
Family
ID=39301650
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070104393 AR063125A1 (es) | 2006-10-04 | 2007-10-03 | Ensayo elisa para la deteccion de vegf |
ARP170100313A AR107561A2 (es) | 2006-10-04 | 2017-02-08 | Ensayo elisa para la detección de vegf |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070104393 AR063125A1 (es) | 2006-10-04 | 2007-10-03 | Ensayo elisa para la deteccion de vegf |
Country Status (25)
Country | Link |
---|---|
US (5) | US20080227119A1 (es) |
EP (3) | EP2069798B1 (es) |
JP (1) | JP6025294B2 (es) |
KR (2) | KR101720887B1 (es) |
CN (2) | CN101523220B (es) |
AR (2) | AR063125A1 (es) |
AU (1) | AU2007319654B2 (es) |
BR (1) | BRPI0715239A2 (es) |
CA (1) | CA2663012C (es) |
DK (2) | DK2069798T3 (es) |
ES (2) | ES2584322T3 (es) |
HK (3) | HK1130090A1 (es) |
HR (1) | HRP20140675T1 (es) |
HU (1) | HUE030082T2 (es) |
IL (1) | IL197374A (es) |
MX (2) | MX2009003562A (es) |
NZ (1) | NZ613646A (es) |
PL (2) | PL2457929T3 (es) |
PT (1) | PT2069798E (es) |
RS (1) | RS53387B (es) |
RU (2) | RU2517301C2 (es) |
SI (2) | SI2069798T1 (es) |
TW (2) | TWI541251B (es) |
WO (1) | WO2008060777A2 (es) |
ZA (1) | ZA200901518B (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050009110A1 (en) * | 2003-07-08 | 2005-01-13 | Xiao-Jia Chang | Methods of producing antibodies for diagnostics and therapeutics |
PL2457929T3 (pl) | 2006-10-04 | 2016-12-30 | Test ELISA dla VEGF | |
WO2011031986A1 (en) | 2009-09-10 | 2011-03-17 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Office Of Technology Transfer, National Institutes Of Health | Assays for soluble il-15 receptor alpha |
KR20130126576A (ko) * | 2010-07-19 | 2013-11-20 | 에프. 호프만-라 로슈 아게 | 항암요법에 반응할 가능성이 증가된 환자를 확인하는 방법 |
WO2012010551A1 (en) * | 2010-07-19 | 2012-01-26 | F. Hoffmann-La Roche Ag | Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy |
CN102207504A (zh) * | 2011-03-23 | 2011-10-05 | 北京华创远航科技有限公司 | 一种酶联检测试剂盒及其制备方法 |
CN102435743B (zh) * | 2011-09-15 | 2014-10-15 | 北京健平九星生物医药科技有限公司 | 一种酶联检测试剂盒及其制备方法 |
CN102426240B (zh) * | 2011-09-19 | 2014-10-15 | 北京健平金星生物科技有限公司 | 一种酶联检测试剂盒及其制备方法 |
KR20140099277A (ko) * | 2011-12-19 | 2014-08-11 | 에프. 호프만-라 로슈 아게 | 다중특이적 결합제의 자유 결합 파트너의 검출 방법 |
KR20140114415A (ko) | 2012-01-13 | 2014-09-26 | 제넨테크, 인크. | Vegf 길항제로의 치료를 위한 환자를 확인하기 위한 생물학적 마커 |
MX349661B (es) * | 2012-02-01 | 2017-08-08 | Hoffmann La Roche | Metodo para la deteccion de una molecula de union de un enlazador multiespecifico. |
CN102645530B (zh) * | 2012-04-06 | 2014-06-18 | 上海蓝怡科技有限公司 | 甲状腺素酶联免疫体外诊断试剂盒中酶结合物稀释液的制备方法 |
MX346146B (es) | 2012-07-13 | 2017-03-09 | Hoffmann La Roche | Metodo para detectar un aglutinante multiespecifico. |
RU2016107435A (ru) | 2013-09-13 | 2017-10-18 | Дженентек, Инк. | Композиции и способы обнаружения и количественного определения белка клеток-хозяев в клеточных линиях и рекомбинантные полипептидные продукты |
WO2015038888A1 (en) | 2013-09-13 | 2015-03-19 | Genentech, Inc. | Methods and compositions comprising purified recombinant polypeptides |
AU2014336016B2 (en) | 2013-10-17 | 2019-12-19 | Sartar Therapeutics Ltd | Compositions comprising phosphodiesterase inhibitors for use in the treatment of a solid tumor in a human patient |
RU2589286C1 (ru) * | 2015-02-03 | 2016-07-10 | Федеральное государственное бюджетное научное учреждение "Томский научно-исследовательский институт онкологии" (Томский НИИ онкологии) | Способ прогнозирования исхода заболевания у больных метастатическим раком почки |
RU2622005C2 (ru) * | 2015-11-24 | 2017-06-08 | Федеральное государственное бюджетное учреждение "Государственный научный центр дерматовенерологии и косметологии" Минздрава России (ФГБУ ГНЦДК Минздрава России) | СПОСОБ ПОЛУЧЕНИЯ СЕЛЕКТИВНОГО ИММУНОСОРБЕНТА ДЛЯ УДАЛЕНИЯ АНТИТЕЛ-IgG К ДЕСМОГЛЕИНУ 3 ТИПА ИЗ СЫВОРОТКИ КРОВИ БОЛЬНЫХ ПУЗЫРЧАТКОЙ |
CN105510595A (zh) * | 2015-12-01 | 2016-04-20 | 邹检平 | 基于量子点CdTe检测人血清中VEGF浓度的试剂盒及其使用方法 |
JP2019523404A (ja) | 2016-07-15 | 2019-08-22 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | 全vegf−aのレベルを検出するための方法及び手段 |
CN107167588A (zh) * | 2017-03-28 | 2017-09-15 | 马杰 | 用于检测血清中血管内皮生长因子的抗体及试剂盒 |
RU2732013C1 (ru) * | 2019-12-11 | 2020-09-10 | Федеральное бюджетное учреждение науки "Государственный научный центр прикладной микробиологии и биотехнологии" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ГНЦ ПМБ) | Способ сенсибилизации планшета для иммуноферментного анализа нерастворимыми белковыми антигенами |
CN111044734A (zh) * | 2019-12-30 | 2020-04-21 | 上海复星长征医学科学有限公司 | 一种用于检测血管内皮生长因子的检测试剂盒及其制备方法和使用方法 |
KR20220157228A (ko) | 2021-05-20 | 2022-11-29 | 대한민국(질병관리청장) | 보툴리눔 독소 a에 특이적인 항체, 이를 생산하는 하이브리도마 세포주, 및 이를 이용한 보툴리눔 독소 a 진단 키트 |
CN117805397A (zh) * | 2024-02-29 | 2024-04-02 | 军科正源(北京)药物研究有限责任公司 | 检测游离vegf的方法 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE337223B (es) | 1967-05-23 | 1971-08-02 | Pharmacia Ab | |
US3720760A (en) | 1968-09-06 | 1973-03-13 | Pharmacia Ab | Method for determining the presence of reagin-immunoglobulins(reagin-ig)directed against certain allergens,in aqueous samples |
FR2046920B1 (es) | 1969-06-19 | 1974-05-03 | Citizen Watch Co Ltd | |
US3691016A (en) | 1970-04-17 | 1972-09-12 | Monsanto Co | Process for the preparation of insoluble enzymes |
US3940475A (en) | 1970-06-11 | 1976-02-24 | Biological Developments, Inc. | Radioimmune method of assaying quantitatively for a hapten |
CA1023287A (en) | 1972-12-08 | 1977-12-27 | Boehringer Mannheim G.M.B.H. | Process for the preparation of carrier-bound proteins |
US4195128A (en) | 1976-05-03 | 1980-03-25 | Bayer Aktiengesellschaft | Polymeric carrier bound ligands |
US4330440A (en) | 1977-02-08 | 1982-05-18 | Development Finance Corporation Of New Zealand | Activated matrix and method of activation |
CA1093991A (en) | 1977-02-17 | 1981-01-20 | Hideo Hirohara | Enzyme immobilization with pullulan gel |
US4229537A (en) | 1978-02-09 | 1980-10-21 | New York University | Preparation of trichloro-s-triazine activated supports for coupling ligands |
US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4737456A (en) | 1985-05-09 | 1988-04-12 | Syntex (U.S.A.) Inc. | Reducing interference in ligand-receptor binding assays |
MX9204374A (es) | 1991-07-25 | 1993-03-01 | Idec Pharma Corp | Anticuerpo recombinante y metodo para su produccion. |
US7005505B1 (en) * | 1995-08-25 | 2006-02-28 | Genentech, Inc. | Variants of vascular endothelial cell growth factor |
US6020473A (en) * | 1995-08-25 | 2000-02-01 | Genentech, Inc. | Nucleic acids encoding variants of vascular endothelial cell growth factor |
DE19532347A1 (de) | 1995-09-04 | 1997-03-06 | Bayer Ag | 4-Thiocarbamoyl-1-(3-pyrazolyl)-pyrazole |
US6750044B1 (en) * | 1996-10-17 | 2004-06-15 | Genentech, Inc. | Variants of vascular endothelial cell growth factor having antagonistic properties, nucleic acids encoding the same and host cells comprising those nucleic acids |
DE69829891T2 (de) | 1997-04-07 | 2005-10-06 | Genentech, Inc., South San Francisco | Anti-VEGF Antikörper |
JP3591264B2 (ja) * | 1997-12-24 | 2004-11-17 | 富士レビオ株式会社 | Vegf121特異的モノクローナル抗体及び測定方法 |
US7078382B1 (en) * | 1999-11-02 | 2006-07-18 | Genentech, Inc. | Modulation of eNOS activity and therapeutic uses thereof |
ATE315789T1 (de) * | 1999-11-16 | 2006-02-15 | Genentech Inc | Elisa für vegf |
RU2271010C2 (ru) * | 2004-03-31 | 2006-02-27 | Общество с ограниченной ответственностью "Фирма МонА" | Способ иммуноферментного анализа для определения фактора виллебранда, моноклональное антитело к фактору виллебранда (варианты) и штамм гибридных культивируемых клеток животных mus. musculus l. - продуцент моноклональных антител к фактору виллебранда (варианты) |
AU2006226891A1 (en) * | 2005-03-24 | 2006-09-28 | Beth Israel Deaconess Medical Center | Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy |
PL2457929T3 (pl) | 2006-10-04 | 2016-12-30 | Test ELISA dla VEGF |
-
2007
- 2007-10-03 PL PL11189401.0T patent/PL2457929T3/pl unknown
- 2007-10-03 AU AU2007319654A patent/AU2007319654B2/en active Active
- 2007-10-03 SI SI200731464T patent/SI2069798T1/sl unknown
- 2007-10-03 WO PCT/US2007/080310 patent/WO2008060777A2/en active Application Filing
- 2007-10-03 MX MX2009003562A patent/MX2009003562A/es unknown
- 2007-10-03 CN CN200780036803.0A patent/CN101523220B/zh active Active
- 2007-10-03 AR ARP070104393 patent/AR063125A1/es active IP Right Grant
- 2007-10-03 PL PL07868362T patent/PL2069798T3/pl unknown
- 2007-10-03 EP EP07868362.0A patent/EP2069798B1/en active Active
- 2007-10-03 HU HUE11189401A patent/HUE030082T2/en unknown
- 2007-10-03 ES ES11189401.0T patent/ES2584322T3/es active Active
- 2007-10-03 DK DK07868362T patent/DK2069798T3/da active
- 2007-10-03 NZ NZ61364607A patent/NZ613646A/en unknown
- 2007-10-03 PT PT78683620T patent/PT2069798E/pt unknown
- 2007-10-03 RS RSP20140350 patent/RS53387B/en unknown
- 2007-10-03 US US11/866,560 patent/US20080227119A1/en not_active Abandoned
- 2007-10-03 BR BRPI0715239-6A2A patent/BRPI0715239A2/pt active Search and Examination
- 2007-10-03 SI SI200731810A patent/SI2457929T1/sl unknown
- 2007-10-03 CN CN201310406549.6A patent/CN103454434B/zh active Active
- 2007-10-03 KR KR1020157005110A patent/KR101720887B1/ko active IP Right Grant
- 2007-10-03 TW TW102139875A patent/TWI541251B/zh active
- 2007-10-03 JP JP2009531581A patent/JP6025294B2/ja active Active
- 2007-10-03 EP EP11189401.0A patent/EP2457929B1/en active Active
- 2007-10-03 ES ES07868362.0T patent/ES2470682T3/es active Active
- 2007-10-03 DK DK11189401.0T patent/DK2457929T3/en active
- 2007-10-03 RU RU2009116611/15A patent/RU2517301C2/ru active
- 2007-10-03 ZA ZA200901518A patent/ZA200901518B/en unknown
- 2007-10-03 EP EP16167119.3A patent/EP3103812B1/en active Active
- 2007-10-03 KR KR1020097009095A patent/KR101551984B1/ko active IP Right Grant
- 2007-10-03 TW TW96137100A patent/TWI429654B/zh active
- 2007-10-03 CA CA2663012A patent/CA2663012C/en active Active
-
2009
- 2009-03-03 IL IL197374A patent/IL197374A/en active IP Right Grant
- 2009-04-02 MX MX2014011461A patent/MX342791B/es unknown
- 2009-10-16 HK HK09109608A patent/HK1130090A1/xx unknown
- 2009-10-16 HK HK12108559.2A patent/HK1168361A1/zh unknown
-
2010
- 2010-06-17 US US12/817,827 patent/US8449885B2/en active Active
-
2012
- 2012-10-25 US US13/660,563 patent/US9146245B2/en active Active
-
2014
- 2014-02-05 RU RU2014104113/15A patent/RU2014104113A/ru not_active Application Discontinuation
- 2014-07-15 HR HRP20140675TT patent/HRP20140675T1/hr unknown
-
2015
- 2015-07-30 US US14/814,139 patent/US9625462B2/en active Active
-
2017
- 2017-02-08 AR ARP170100313A patent/AR107561A2/es unknown
- 2017-03-13 US US15/456,846 patent/US20170276683A1/en not_active Abandoned
- 2017-06-13 HK HK17105832.2A patent/HK1232236A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR107561A2 (es) | Ensayo elisa para la detección de vegf | |
Ma et al. | Ratiometric semiconducting polymer nanoparticle for reliable photoacoustic imaging of pneumonia-induced vulnerable atherosclerotic plaque in vivo | |
ATE315789T1 (de) | Elisa für vegf | |
CN102841208B (zh) | 快速检测肌钙蛋白i的胶体金试纸及其制备方法 | |
Shin et al. | Association between fasting serum glucose levels and incidence of colorectal cancer in Korean men: the Korean Cancer Prevention Study-II | |
WO2006073682A3 (en) | Diagnostic test | |
MX2010006484A (es) | Composiciones y metodos para detectar anticuerpos de infidelidad de transcripcion (tiab). | |
CN101025415A (zh) | 一种检测尿液中尿酸含量范围的试纸 | |
EA201590686A1 (ru) | Тест на митохондриальную токсичность | |
ES2531368T3 (es) | Métodos y kits para diagnosticar tumorigenicidad y determinar resistencia a los efectos antineoplásicos de la terapia antiestrógeno | |
Koenig et al. | Usefulness of whole blood, plasma, peritoneal fluid, and peritoneal fluid supernatant glucose concentrations obtained by a veterinary point-of-care glucometer to identify septic peritonitis in dogs with peritoneal effusion | |
CN106461677A (zh) | 肺高血压病的检查方法 | |
van den Brink et al. | Digital resilience biomarkers for personalized health maintenance and disease prevention | |
Kosmicki et al. | Noninvasive prediction of left ventricular systolic dysfunction in patients with clinically suspected heart failure using acoustic cardiography | |
La Favor et al. | A microdialysis method to measure in vivo hydrogen peroxide and superoxide in various rodent tissues | |
CN104569437B (zh) | 用于评估女性24小时尿钠值的试剂盒 | |
CN105929168A (zh) | 乳腺癌肿瘤标志物ca153的双阈值检测试纸 | |
CY1115197T1 (el) | Elisa για vegf | |
CY1112415T1 (el) | Η πρωτεϊνη serum amyloid p-component (sap, samp) ως προγνωστικος και διαγνωστικος δεικτης για τον προγεννητικο ελεγχο της τρισωμιας 21 (συνδρομο down) | |
TH106073A (th) | การทดสอบวิเคราะห์ elisa สำหรับตรวจหา vegf | |
RU2314040C1 (ru) | Способ диагностики острого пиелонефрита у детей | |
Zhang et al. | Saliva: linking oral health with heart failure | |
Franca et al. | Vascular inflammation exposes perivascular cells to SARS-CoV-2 infection | |
樋渡敬介 et al. | Feasibility of measuring urine glucose concentrations by a digital meter in dogs and cats | |
Pardy et al. | 711 URINARY LYSINE IS A BETTER PREDICTOR OF CYSTINE STONE FORMATION AND PROGRESSION THAN URINARY CYSTINE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |